Radiopharmaceutical therapy in cancer: clinical advances and challenges
Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach
to treating many types of cancer. In RPT, radiation is systemically or locally delivered using …
to treating many types of cancer. In RPT, radiation is systemically or locally delivered using …
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
V Ambrosini, J Kunikowska, E Baudin, L Bodei… - European journal of …, 2021 - Elsevier
Nuclear medicine plays an increasingly important role in the management neuroendocrine
neoplasms (NEN). Somatostatin analogue (SSA)-based positron emission …
neoplasms (NEN). Somatostatin analogue (SSA)-based positron emission …
[HTML][HTML] Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Pavel, K Öberg, M Falconi, EP Krenning, A Sundin… - Annals of …, 2020 - Elsevier
Neuroendocrine neoplasms (NENs) arise from the diffuse neuroendocrine cell system and
may occur at many different disease sites. Most frequently, these neoplasms occur in the …
may occur at many different disease sites. Most frequently, these neoplasms occur in the …
Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States
Importance The incidence and prevalence of neuroendocrine tumors (NETs) are thought to
be rising, but updated epidemiologic data are lacking. Objective To explore the evolving …
be rising, but updated epidemiologic data are lacking. Objective To explore the evolving …
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J Strosberg, G El-Haddad, E Wolin… - … England Journal of …, 2017 - Mass Medical Soc
Background Patients with advanced midgut neuroendocrine tumors who have had disease
progression during first-line somatostatin analogue therapy have limited therapeutic options …
progression during first-line somatostatin analogue therapy have limited therapeutic options …
The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors
JR Howe, NB Merchant, C Conrad, XM Keutgen… - Pancreas, 2020 - journals.lww.com
This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the surgical management of pancreatic neuroendocrine tumors …
consensus conference on the surgical management of pancreatic neuroendocrine tumors …
ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine …
Only advances that occurred from 2011 to 2014 that either strengthen the previous 2011
guidelines [1, 2] or lead to changes or additional guidelines are reviewed here. Advances …
guidelines [1, 2] or lead to changes or additional guidelines are reviewed here. Advances …
ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN …
M Pavel, D O''Toole, F Costa, J Capdevila… - …, 2016 - karger.com
M. Pavel a D. O'Toole b F. Costa c J. Capdevila d D. Gross e R. Kianmanesh f E. Krenning g
U. Knigge h R. Salazar i U.-F. Pape a K. Öberg j all other Vienna Consensus Conference …
U. Knigge h R. Salazar i U.-F. Pape a K. Öberg j all other Vienna Consensus Conference …
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors
T Brabander, WA van der Zwan, JJM Teunissen… - Clinical Cancer …, 2017 - AACR
Purpose: Bronchial and gastroenteropancreatic neuroendocrine tumors (NET) are slow-
growing tumors, which frequently express somatostatin receptors on their cell membranes …
growing tumors, which frequently express somatostatin receptors on their cell membranes …
Targeted α-emitter therapy with 212Pb-DOTAMTATE for the treatment of metastatic SSTR-expressing neuroendocrine tumors: first-in-humans dose-escalation clinical …
ES Delpassand, I Tworowska… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Peptide receptor radiotherapy with somatostatin analogs has been successfully used for
years as a treatment for somatostatin-overexpressing tumors. Treatment of neuroendocrine …
years as a treatment for somatostatin-overexpressing tumors. Treatment of neuroendocrine …